{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Jatenzo&page=2", "query": { "intervention": "Jatenzo", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 214, "total_pages": 22, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Jatenzo&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Jatenzo&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T04:16:05.531Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01228071", "title": "Time to Eugonadal Range, Time to Steady State and Drying Time", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Male Hypogonadism" ], "interventions": [ { "name": "testosterone gel 2%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endo USA Inc., a Keenova Therapeutics Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 34, "start_date": "2010-11", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2017-10-05", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 8, "location_summary": "Tucson, Arizona • Middlebury, Connecticut • Oviedo, Florida + 5 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Middlebury", "state": "Connecticut" }, { "city": "Oviedo", "state": "Florida" }, { "city": "Tallahassee", "state": "Florida" }, { "city": "Brookline", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01228071" }, { "nct_id": "NCT01460654", "title": "Testosterone and Alendronate in Hypogonadal Men", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypogonadism", "Osteopenia", "Osteoporosis" ], "interventions": [ { "name": "Testosterone", "type": "DRUG" }, { "name": "Alendronate", "type": "DRUG" }, { "name": "Placebo Alendronate", "type": "DRUG" }, { "name": "Placebo Testosterone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": "85 Years", "sex": "MALE", "summary": "60 Years to 85 Years · Male only" }, "enrollment_count": 44, "start_date": "2011-10", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2023-10-12", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01460654" }, { "nct_id": "NCT00857961", "title": "A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypogonadism" ], "interventions": [ { "name": "Testosterone MD-Lotion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "18 Years to 70 Years · Male only" }, "enrollment_count": 21, "start_date": "2007-10", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2011-01-07", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 4, "location_summary": "Tuscon, Arizona • Burbank, California • New Britain, Connecticut + 1 more", "locations": [ { "city": "Tuscon", "state": "Arizona" }, { "city": "Burbank", "state": "California" }, { "city": "New Britain", "state": "Connecticut" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00857961" }, { "nct_id": "NCT06455969", "title": "Adaptions and Resiliency to Multi-Stressor OpeRations", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Musculoskeletal Injury", "Hypogonadism", "Hormonal Contraception" ], "interventions": [ { "name": "Goserelin 3.6 MG", "type": "DRUG" }, { "name": "Multi-Stressor Training", "type": "OTHER" }, { "name": "Testosterone gel (AndroGel 5g)", "type": "DRUG" }, { "name": "Testosterone gel (AndroGel 1.25g)", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bradley Nindl", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 120, "start_date": "2024-07-15", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06455969" }, { "nct_id": "NCT00983554", "title": "Metabolic Effects of Steroids in Obese Men", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Insulin Resistance" ], "interventions": [ { "name": "Anastrazole", "type": "DRUG" }, { "name": "Testosterone", "type": "DRUG" }, { "name": "Dutasteride", "type": "DRUG" }, { "name": "GnRH antagonist", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "24 Years", "maximum_age": "51 Years", "sex": "MALE", "summary": "24 Years to 51 Years · Male only" }, "enrollment_count": 57, "start_date": "2005-06", "completion_date": "2009-10", "has_results": false, "last_update_posted_date": "2011-03-16", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 2, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00983554" }, { "nct_id": "NCT01725451", "title": "A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Testosterone", "type": "DRUG" }, { "name": "Deodorant Spray", "type": "OTHER" }, { "name": "Deodorant and Antiperspirant Combination Spray", "type": "OTHER" }, { "name": "Deodorant and Antiperspirant Combination Stick", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "MALE", "summary": "50 Years and older · Male only" }, "enrollment_count": 30, "start_date": "2012-11", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2014-10-16", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Evansville, Indiana", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01725451" }, { "nct_id": "NCT01327495", "title": "PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "placebo acyline", "type": "OTHER" }, { "name": "placebo gel", "type": "OTHER" }, { "name": "Testosterone 1% gel 1.25 g", "type": "DRUG" }, { "name": "Testosterone 1% gel 2.5 g", "type": "DRUG" }, { "name": "Testosterone 1% gel 5.0 g", "type": "DRUG" }, { "name": "testosterone 1% gel 10 g", "type": "DRUG" }, { "name": "testosterone 1% gel 15 g", "type": "DRUG" }, { "name": "Acyline", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "25 Years to 55 Years · Male only" }, "enrollment_count": 62, "start_date": "2011-10", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2017-10-05", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01327495" }, { "nct_id": "NCT00490555", "title": "PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Testosterone gel", "type": "DRUG" }, { "name": "Dutasteride", "type": "DRUG" }, { "name": "Depo-Medroxyprogesterone (DMPA)", "type": "DRUG" }, { "name": "Placebo Testosterone gel", "type": "OTHER" }, { "name": "Placebo dutasteride", "type": "OTHER" }, { "name": "Placebo DMPA", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "25 Years to 55 Years · Male only" }, "enrollment_count": 32, "start_date": "2009-01", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2013-11-15", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00490555" }, { "nct_id": "NCT01215292", "title": "ITT4 Intratesticular Hormonal Milieu in Man (ITT4)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy Males" ], "interventions": [ { "name": "Acyline", "type": "DRUG" }, { "name": "Testosterone gel", "type": "DRUG" }, { "name": "ketoconazole 400", "type": "DRUG" }, { "name": "Ketoconazole 800", "type": "DRUG" }, { "name": "Dutasteride", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Placebo ketoconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 46, "start_date": "2011-01", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2014-03-31", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01215292" }, { "nct_id": "NCT02679274", "title": "Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Aging" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Testosterone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Medical Branch, Galveston", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 3, "start_date": "2016-02-16", "completion_date": "2016-09-20", "has_results": true, "last_update_posted_date": "2019-02-18", "last_synced_at": "2026-10-01T04:16:05.531Z", "location_count": 2, "location_summary": "Galveston, Texas • Texas City, Texas", "locations": [ { "city": "Galveston", "state": "Texas" }, { "city": "Texas City", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02679274" } ] }